rTMS for Depression

NCT06484413 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2024-07-03

No results posted yet for this study

Summary

This is a longitudinal observational study, where we will track outcomes in patients undergoing 5 weeks of FDA approved right DLPFC rTMS treatment.

Conditions

Sponsors & Collaborators

  • Northwell Health

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-23
Primary Completion
2020-02-25
Completion
2022-04-19

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06484413 on ClinicalTrials.gov